Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: other route
Adequacy of study:
other information
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: Summary report: no detailed information, secondary literature; route of application not relevant for humans.

Data source

Reference
Reference Type:
publication
Title:
Etude toxicologique de la formamide et de ses dérivés N-Méthylés et N-Ethylés.
Author:
Chanh PH, Xuong ND, Azum-Gelade M-C
Year:
1971
Bibliographic source:
Thérapie 26, 409-424.

Materials and methods

Principles of method if other than guideline:
Method: other: according to Caujolle, F. et al.: Arzneimittelforschung 20: 1242-1246
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Formamide
EC Number:
200-842-0
EC Name:
Formamide
Cas Number:
75-12-7
Molecular formula:
CH3NO
IUPAC Name:
formamide
Details on test material:
TS-Freetext:
formamide; no data on purity of the compound

Test animals

Species:
rat
Strain:
Wistar
Sex:
male

Administration / exposure

Route of administration:
intraperitoneal
Duration of treatment / exposure:
7 weeks
Frequency of treatment:
once daily, 5 d/wk
Doses / concentrations
Remarks:
Doses / Concentrations:
150 mg/kg
Control animals:
yes, concurrent vehicle
Details on study design:
Post-exposure period: 24 h

Results and discussion

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

RS-Freetext:
Depression of body weight gain, leukocytosis, elevated SGOT
and SGPT in blood. No microscopic histological changes in
various tissues.

Applicant's summary and conclusion